See also this year's filing and all EDGAR filings for this company.
PDF Report 0001657312_2021_Verona_Pharma_plc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001657312, Verona Pharma plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 202,504,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 545,000 |
| 2 | PropertyPlantAndEquipmentNet | 107,000 |
| 3 | remainder_Assets | 1,050,000 |
| 4 | LiabilitiesCurrent | 14,203,000 |
| 5 | LiabilitiesNoncurrent | 5,149,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,772,000 |
| 9 | ResearchAndDevelopmentExpense | 44,505,000 |
| 10 | remainder_Expenses | 146,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 9,277,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,321,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 204,206,000 |
| 1 | Liabilities | 19,352,000 |
| 2 | Expenses | 74,423,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 184,854,000 |
| 5 | NetIncome | -65,146,000 |
| 6 | ComprehensiveNetIncome | -66,306,500 |
| 7 | BaseVar | 154,789,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.01 |
| 9 | EconomicCapitalRatio | 3.69 |
Edgar->Model Mapping
Feature Distribution
